Literature DB >> 6740681

Postnatal ontogeny of metallothionein in various organs of the rat.

M P Waalkes, C D Klaassen.   

Abstract

Newborn rats have high levels of hepatic metallothionein (MT) which decreased to adult levels by 1 month of age. However, little is known about MT in other organs during this period. Therefore, this study was designed to estimate the MT concentration of major organs during postnatal development. Various tissues were assayed for MT on Days 1, 7, 14, 21, 28, and 35 postpartum and compared to levels in adult rats. The highest concentration of MT was found in liver of 1-day-old rats followed by testes, kidney, spleen, pancreas, intestine, stomach, lung, and brain. Levels in all organs except brain were 2- to 90-fold higher in 1-day-old than adult rats. Hepatic MT remained high for the first week and then decreased steadily to adult levels by Day 28. Concentrations in spleen, pancreas, and heart fell steadily to adult values by 3 to 4 weeks while lung MT levels declined much more rapidly. Renal MT was highest on Day 14 and then decreased to adult values by Day 28. Levels in intestine and stomach remained constant until decreasing to adult values on Day 28. Neonatal brain had lower MT concentrations than adult brain, increasing to adult levels by Day 21. Testicular MT concentrations were 50% higher than adult concentrations on Day 1, decreased to 40% of adult levels by 1 week, and stabilized at adult levels by 2 weeks of age. Cd treatment (3 mg Cd/kg, iv) of 1-week-old rats elevated MT concentrations in all organs except liver, testes, and brain. Zn treatment (20 mg Zn/kg, iv) increased MT concentrations only in liver, kidney, intestine, pancreas, and spleen. The increase in MT concentration in the pancreas following Zn treatment was the most marked of any organ; levels here increased to approximately 2000% of control. Results indicate that MT levels in most neonatal tissues were higher than in adults and that the postnatal ontogeny of MT is organ specific.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6740681     DOI: 10.1016/0041-008x(84)90284-9

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  8 in total

1.  Induction of metallothionein in rat tissues following subchronic exposure to mercury shown by radioimmunoassay.

Authors:  C V Nolan; Z A Shaikh
Journal:  Biol Trace Elem Res       Date:  1987-04       Impact factor: 3.738

2.  Transforming growth factor alpha: a promoter of motoneuron survival of potential biological relevance.

Authors:  S Boillée; J Cadusseau; M Coulpier; G Grannec; M P Junier
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

3.  State of iron repletion and cadmium tissue accumulation as a function of growth in young rats after oral cadmium exposure.

Authors:  K Schümann; P Friebel; G Schmolke; B Elsenhans
Journal:  Arch Environ Contam Toxicol       Date:  1996-11       Impact factor: 2.804

Review 4.  Factors influencing susceptibility to metals.

Authors:  M Gochfeld
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

5.  Effect of age on cadmium-induced metallothionein synthesis in the rat.

Authors:  U Wormser; I Nir
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

6.  Effects of cadmium exposure on zinc and copper distribution in neonatal rats.

Authors:  D J Thomas; P Mushak
Journal:  Arch Toxicol       Date:  1986-02       Impact factor: 5.153

7.  In vitro assessment of target cell specificity in cadmium carcinogenesis: interactions of cadmium and zinc with isolated interstitial cells of the rat testes.

Authors:  M P Waalkes; A Perantoni
Journal:  In Vitro Cell Dev Biol       Date:  1988-06

8.  Increased metallothionein I/II expression in patients with temporal lobe epilepsy.

Authors:  José Eduardo Peixoto-Santos; Orfa Yineth Galvis-Alonso; Tonicarlo Rodrigues Velasco; Ludmyla Kandratavicius; João Alberto Assirati; Carlos Gilberto Carlotti; Renata Caldo Scandiuzzi; Luciano Neder Serafini; João Pereira Leite
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.